Regulation of local host-mediated anti-tumor mechanisms by cytokines: Direct and indirect effects on leukocyte recruitment and angiogenesis

American Journal of Pathology

Volumn 150, Issue 5, 1997, Pages 1869-1880

  Watanabe, Morihiro ^a   McCormick, Kathryn L ^a   Volker, Kirk ^a   Ortaldo, John R ^a   Wigginton, Jon M ^a   Brunda, Michael J ^b   Wiltrout, Robert H ^a   Fogler, William E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Department of Oncology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER; CANCER IMMUNOLOGY; LEUKOCYTE ACTIVATION; LEUKOCYTE MIGRATION; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL DIVISION; CELL MOVEMENT; CYTOKINES; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; GELATIN SPONGE, ABSORBABLE; HUMANS; INTERLEUKIN-12; INTERLEUKIN-2; LEUKOCYTES; MELANOMA; MICE; MICE, INBRED C57BL; MICE, SCID; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; RECOMBINANT PROTEINS; TUMOR CELLS, CULTURED;

EID: 0031000838     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1995, 1:27-31
2. Dvorak HF, Dvorak AM: Immunohistochemical characterization of inflammatory cells that infiltrate tumors. Tumor Immunity in Prognosis: The Role of Mononuclear Cell Infiltration. Edited by S Haskill. New York, Marcel Dekker, 1982, pp 279-302
3. Hogg N, Berlin C: Structure and function of adhesion receptors in leukocyte trafficking. Immunol Today 1995, 16:327-330
4. Carlos TM, Harlan JM: Leukocyte-endothelial adhesion molecules. Blood 1994, 84:2068-2101
5. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994, 76:301-314
6. Bevilacqua MP: Endothelial-leukocyte adhesion molecules. Annu Rev Immunol 1993, 11:767-804
7. Ben-Baruch A, Michiel DF, Oppenheim JJ: Signals and receptors involved in recruitment of inflammatory cells. J Biol Chem 1995, 270:11703-11706
8. DeVita VT, Hellman S, Rosenberg SA: Biological Therapy of Cancer. Philadelphia, JB Lippincott Co, 1995
9. Friesel RE, Maciag T: Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction. FASEB J 1995, 9:919-925
10. Burgess WH, Winkles JA: The fibroblast growth factor family: multifunctional regulators of cell proliferation. Regulation of the Proliferation of Neoplastic Cells. Edited by L Pusztai, CE Lewis, E Yap. Oxford, Oxford University Press, 1994, pp 155-218
11. Klagsbrun M, Soker S: VEGF/VPF: the angiogenesis factor found? Curr Biol 1993, 3:699-702
12. Dvorak HF, Brown LF, Detmar M, Dvorak AM: Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995, 146:1029-1039
13. Claffey KP, Brown LF, Aguila LF del, Tognazzi K, Yeo K-T, Manseau J, Dvorak HF: Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis. Cancer Res 1996, 56:172-181
14. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman JA: Angiostatin: a novel angiogenesis inhibitor that medi- ates the suppression of metastases by a Lewis lung carcinoma. Cell 1994, 79:315-328
15. Volpert OV, Stellmach V, Bouck N: The modulation of thrombospondin and other naturally occurring inhibitors of angiogenesis during tumor progression. Breast Cancer Res Treat 1995, 36:119-126
16. Folkman J: Angiogenesis inhibitors generated by tumors. Mol Med 1995, 1:120-122
17. Koch AE, Halloran MM, Haskell CJ, Shah MR, Polverini PJ: Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 1995, 376:517-519
18. Melder RJ, Koenig GC, Witwer BP, Safabakhsh N, Munn LL, Jain RK: During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. Nature Med 1996, 2:992-997
19. Strieter RM, Polverini PJ, Arenberg DA, Kunkel SL: The role of CXC chemokines as regulators of angiogenesis. Shock 1995, 4:155-160
20. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, Elner SG, Strieter RM: Interleukin-8 (IL-8) as a macrophage-derived mediator of angiogenesis. Science 1992, 258:1798-1801
21. Strieter RM, Kunkel SL, Elner VM, Martonyl CL, Koch AE, Polverini PJ, Elner SG: Interleukin-8: a corneal factor that induces neovascularization. Am J Pathol 1992, 141:1279-1284
22. Cao Y, Chen C, Weatherbee JA, Tsang M, Folkman J: gro-β, a -C-X-C- chemokine, is an angiogenesis inhibitor that suppresses the growth of Lewis lung carcinoma in mice. J Exp Med 1995, 182:2069-2077
23. Angiolillo AI, Sgadari C, Taub DD, Liao F, Farber JM, Maheshwari S, Kleinman HK, Reaman GH, Tosato G: Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J Exp Med 1995, 182:155-162
24. Fogler WE, Volker K, McCormick KL, Watanabe M, Ortaldo JR, Wiltrout RH: NK cell distribution into lung, liver, and subcutaneous B16 melanoma is mediated by VCAM-1/VLA-4 interaction. J Immunol 1996, 156:4707-4714
25. Melder RJ, Salehi HA, Jain RK: Interaction of activated natural killer cells with normal and tumor vessels in cranial windows in mice. Microvasc Res 1995, 50:35-44
26. Melani C, Pupa SM, Stoppacciaro A, Menard S, Colnaghi MI, Parmiani G, Colombo MP: An in vivo model to compare human leukocyte infiltration in carcinoma xenografts producing different chemokines. Int J Cancer 1995, 62:572-578
27. Basse P, Herberman RB, Nannmark U, Johansson BR, Hokland M, Wasserman K, Goldfarb RH: Accumulation of adoptively transferred adherent lymphokine-activated killer cells in murine metastases. J Exp Med 1991, 174:479-488
28. Griffith KD, Read EJ, Carrasquillo JA, Carter CS, Yang JC, Fisher B, Aebersold P, Packard BS, Yu MY, Rosen- berg SA: In vivo distribution of adoptively transferred indium-111-labeled tumor infiltrating lymphocytes and peripheral blood lymphocytes in patients with metastatic melanoma. J Natl Cancer Inst 1989, 81:1709-1717
29. Chen C, Parangi S, Tolentino MJ, Folkman J: A strategy to discover circulating angiogenesis inhibitors generated by human tumors. Cancer Res 1995, 55:4230-4233
30. Kibbey MC, Corcoran ML, Wahl LM, Kleinman HK: Laminin SIKVAV peptide-induced angiogenesis in vivo is potentiated by neutrophils. J Cell Physiol 1994, 160:185-193
31. Pili R, Guo Y, Chang J, Nakanishi H, Martin GR, Passaniti A: Altered angiogenesis underlying age-dependent changes in tumor growth. J Natl Cancer Inst 1994, 86:1303-1314
32. MacPhee MJ, Wiltrout RH, McCormick KL, Sayers TJ, Pilaro AM: A method for obtaining and culturing large numbers of purified organ-derived murine endothelial cells. J Leukocyte Biol 1994, 55:467-475
33. Thompson JA, Anderson KD, DiPietro JM, Zwiebel JA, Zametta M, Anderson WF, Maciag T: Site-directed neovessel formation in vivo. Science 1988, 241:1349-1352
34. Park JA, Brown RA, Kurt RA, Akporiaye ET: Studies of in vivo recruitment and activation of cytotoxic lymphocytes using a gelatin-sponge model of concomitant tumor immunity. Int J Cancer 1995, 62:421-427
35. Wigginton JM, Komschlies KL, Back TC, Franco JL, Brunda MJ, Wiltrout RH: Administration of interleukin 12 with pulse interleukin 2 and the rapid and complete eradication of murine renal carcinoma. J Natl Cancer Inst 1996, 88:38-43
36. Pilaro AM, Taub DD, McCormick KL, Williams HM, Sayers TJ, Fogler WE, Wiltrout RH: TNF-α is a principal cytokine involved in the recruitment of NK cells to liver parenchyma. J Immunol 1994, 153:333-342
37. Watanabe H, Ohtsuka K, Kimura M, Ikarashi Y, Ohmori K, Kusumi A, Ohteki T, Seki S, Abo T: Details of an isolation method for hepatic lymphocytes in mice. J Immunol Methods 1992, 146:145-154
38. v integrins. Science 1995, 270:1500-1502
39. Lotze MT: Biologic therapy with interleukin-2: preclinical studies. Biological Therapy of Cancer. Edited by VT DeVita, S Hellman, SA Rosenberg. Philadelphia, JB Lippincott Co, 1995, pp 207-234
40. Trinchieri G: Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995, 13:251-276
41. Magram J, Connaughton SE, Warrier RR, Carvajal DM, Wu C, Ferrante J, Stewart C, Sarmiento U, Faherty DA, Gately MK: IL-12-deficient mice are defective in IFNγ production and type 1 cytokine responses. Immunity 1996, 4:471-481
42. Voest EE, Kenyon BM, O'Reilly MS, Truitt G, D'Amato RJ, Folkman J: inhibition of angiogenesis in vivo by interleukin 12. J Natl Cancer Inst 1995, 87:581-586
43. Sgadari, C, Angiolillo AL, Tosato G: Inhibition of angiogenesis by interleukin-12 is mediated by the interferoninducible protein 10. Blood 1996, 87:3877-3882
44. Dahmen, U, Bergese SD, Qian S, Pelletier RP, Wu H, Sedmak DD, Fung JJ, Orosz CG: Patterns of inflammatory vascular endothelial changes in murine liver grafts. Transplantation 1995, 60:577-584
45. Bergese SD, Pelletier RP, Ohye RG, Vallera DA, Orosz CG: Treatment of mice with anti-CD3 mAb induces endothelial vascular cell adhesion molecule-1 expression. Transplantation 1994, 57:711-717
46. Pelletier RP, Morgan CJ, Sedmak DD, Miyake K, Kincade PW, Ferguson RM, Orosz CG: Analysis of inflammatory endothelial changes, including VCAM-1 expression, in murine cardiac grafts. Transplantation 1993, 55:315-320
47. Wu NZ, Klitzman B, Dodge R, Dewhirst MW: Diminished leukocyte-endothelium interaction in tumor microvessels. Cancer Res 1992, 52:4265-4268
48. Nannmark U, Johansson BR, Bryant JL, Unger ML, Hokland ME, Goldfarb RH, Basse PH: Microvessel origin and distribution in pulmonary metastases of B16 melanoma: implication for adoptive immunotherapy. Cancer Res 55:4627-4632
49. Griffioen AW, Damen CA, Blijham GH, Groenewegen G: Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor-associated endothelium. Blood 1996, 88:667-673
50. Fidler IJ: Modulation of the organ microenvironment for treatment of cancer metastasis. J Natl Cancer Inst 1995, 87:1588-1592
51. Fidler IJ, Ellis LM: The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 1994, 79:185-188